• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内急性早幼粒细胞白血病进展的时间分辨率揭示了 在抑制早期白血病转化中的作用。

In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of in suppressing early leukemic transformation.

机构信息

Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona 08003, Spain.

Department of Experimental Oncology, European Institute of Oncology (IEO), Milan 20139, Italy.

出版信息

Genes Dev. 2022 Apr 1;36(7-8):451-467. doi: 10.1101/gad.349115.121. Epub 2022 Apr 21.

DOI:10.1101/gad.349115.121
PMID:35450883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9067408/
Abstract

Genome organization plays a pivotal role in transcription, but how transcription factors (TFs) rewire the structure of the genome to initiate and maintain the programs that lead to oncogenic transformation remains poorly understood. Acute promyelocytic leukemia (APL) is a fatal subtype of leukemia driven by a chromosomal translocation between the promyelocytic leukemia (PML) and retinoic acid receptor α (RARα) genes. We used primary hematopoietic stem and progenitor cells (HSPCs) and leukemic blasts that express the fusion protein PML-RARα as a paradigm to temporally dissect the dynamic changes in the epigenome, transcriptome, and genome architecture induced during oncogenic transformation. We found that PML-RARα initiates a continuum of topologic alterations, including switches from A to B compartments, transcriptional repression, loss of active histone marks, and gain of repressive histone marks. Our multiomics-integrated analysis identifies as an early down-regulated gene in PML-RARα-driven leukemogenesis. Furthermore, we characterized the dynamic alterations in the -regulatory network during APL progression and demonstrated that ectopic overexpression can suppress self-renewal and reverse the differentiation block induced by PML-RARα. Our study provides a comprehensive in vivo temporal dissection of the epigenomic and topological reprogramming induced by an oncogenic TF and illustrates how topological architecture can be used to identify new drivers of malignant transformation.

摘要

基因组组织在转录中起着关键作用,但转录因子 (TFs) 如何重塑基因组结构以启动和维持导致致癌转化的程序仍知之甚少。急性早幼粒细胞白血病 (APL) 是一种致命的白血病亚型,由早幼粒细胞白血病 (PML) 和维甲酸受体 α (RARα) 基因之间的染色体易位驱动。我们使用表达融合蛋白 PML-RARα 的原代造血干/祖细胞 (HSPC) 和白血病母细胞作为范例,从时间上解析致癌转化过程中诱导的表观基因组、转录组和基因组结构的动态变化。我们发现 PML-RARα 引发了一系列拓扑变化,包括从 A 到 B 隔室的转变、转录抑制、活性组蛋白标记的丧失和抑制性组蛋白标记的获得。我们的多组学综合分析将 确定为 PML-RARα 驱动的白血病发生中的早期下调基因。此外,我们描述了 APL 进展过程中 - 调节网络的动态变化,并表明异位 过表达可以抑制自我更新并逆转 PML-RARα 诱导的分化阻滞。我们的研究提供了对致癌 TF 诱导的表观基因组和拓扑重编程的全面体内时间剖析,并说明了拓扑结构如何用于鉴定恶性转化的新驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/b08a4aecaa7e/451f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/f45fe73e8d40/451f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/c02cdca343ad/451f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/7ee1a00550cc/451f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/986cd4f61690/451f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/b08a4aecaa7e/451f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/f45fe73e8d40/451f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/c02cdca343ad/451f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/7ee1a00550cc/451f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/986cd4f61690/451f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b3/9067408/b08a4aecaa7e/451f05.jpg

相似文献

1
In vivo temporal resolution of acute promyelocytic leukemia progression reveals a role of in suppressing early leukemic transformation.体内急性早幼粒细胞白血病进展的时间分辨率揭示了 在抑制早期白血病转化中的作用。
Genes Dev. 2022 Apr 1;36(7-8):451-467. doi: 10.1101/gad.349115.121. Epub 2022 Apr 21.
2
Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.由PML/RARα结合导致的CDKN2C抑制促进急性早幼粒细胞白血病中的增殖和分化阻滞。
Front Med. 2016 Dec;10(4):420-429. doi: 10.1007/s11684-016-0478-3. Epub 2016 Dec 23.
3
Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.核受体共抑制因子与早幼粒细胞白血病(PML)及早幼粒细胞白血病锌指蛋白(PLZF)-维甲酸受体α(RARα)结合时视黄酸敏感性降低是急性早幼粒细胞白血病分子发病机制及治疗的基础。
Blood. 1998 Apr 15;91(8):2634-42.
4
Two critical hits for promyelocytic leukemia.早幼粒细胞白血病的两次关键打击。
Mol Cell. 2000 Nov;6(5):1131-41. doi: 10.1016/s1097-2765(00)00111-8.
5
DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.DNA 甲基化变化是急性早幼粒细胞白血病的晚期事件,与转录因子结合的丧失同时发生。
Blood. 2013 Jan 3;121(1):178-87. doi: 10.1182/blood-2012-08-448860. Epub 2012 Nov 14.
6
Understanding the molecular pathogenesis of acute promyelocytic leukemia.了解急性早幼粒细胞白血病的分子发病机制。
Best Pract Res Clin Haematol. 2014 Mar;27(1):3-9. doi: 10.1016/j.beha.2014.04.006. Epub 2014 Apr 13.
7
Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.HOX 基因低表达导致 PML-RARα 阳性白血病。
Epigenetics. 2018;13(1):73-84. doi: 10.1080/15592294.2017.1413517. Epub 2018 Feb 7.
8
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein.半胱天冬酶介导维甲酸诱导的急性早幼粒细胞白血病PML/RARα融合蛋白的降解。
Blood. 1998 Oct 1;92(7):2244-51.
9
Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia.阻断泛素蛋白酶 UBP43 可使转录因子 PML/RARα 失稳,并抑制急性早幼粒细胞白血病的生长。
Cancer Res. 2010 Dec 1;70(23):9875-85. doi: 10.1158/0008-5472.CAN-10-1100. Epub 2010 Oct 8.
10
Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.鉴定B94(TNFAIP2)为急性早幼粒细胞白血病中潜在的视黄酸靶基因。
Cancer Res. 2000 Apr 1;60(7):1824-9.

本文引用的文献

1
Productive visualization of high-throughput sequencing data using the SeqCode open portable platform.使用 SeqCode 开放便携平台对高通量测序数据进行高效可视化。
Sci Rep. 2021 Oct 1;11(1):19545. doi: 10.1038/s41598-021-98889-7.
2
Tumor suppressor function of Gata2 in acute promyelocytic leukemia.Gata2 在急性早幼粒细胞白血病中的肿瘤抑制功能。
Blood. 2021 Sep 30;138(13):1148-1161. doi: 10.1182/blood.2021011758.
3
Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells.Krüppel样因子4促进急性髓系白血病细胞的存活和增殖。
Oncotarget. 2021 Feb 16;12(4):255-267. doi: 10.18632/oncotarget.27878.
4
A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia.PML/RARα 直接靶标图谱重新定义了急性早幼粒细胞白血病中的转录失调。
Blood. 2021 Mar 18;137(11):1503-1516. doi: 10.1182/blood.2020005698.
5
Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia.PML-RARα 通过染色质拓扑重排抑制急性早幼粒细胞白血病中的转录。
Genome Biol. 2020 May 11;21(1):110. doi: 10.1186/s13059-020-02030-2.
6
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer.染色质折叠域被体细胞基因组重排破坏与人类癌症相关。
Nat Genet. 2020 Mar;52(3):294-305. doi: 10.1038/s41588-019-0564-y. Epub 2020 Feb 5.
7
RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.RUNX1-ETO 缺失导致 t(8;21) AML 中增强子-启动子相互作用发生 C/EBPα 和 AP-1 介导的改变。
Cell Rep. 2019 Sep 17;28(12):3022-3031.e7. doi: 10.1016/j.celrep.2019.08.040.
8
A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.KLF4-DYRK2 介导的通路调控 CML 干细胞自我更新。
Blood. 2019 Nov 28;134(22):1960-1972. doi: 10.1182/blood.2018875922.
9
The role of 3D genome organization in development and cell differentiation.三维基因组组织在发育和细胞分化中的作用。
Nat Rev Mol Cell Biol. 2019 Sep;20(9):535-550. doi: 10.1038/s41580-019-0132-4.
10
EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.EFL1 突变会影响 eIF6 的释放,从而导致 Shwachman-Diamond 综合征。
Blood. 2019 Jul 18;134(3):277-290. doi: 10.1182/blood.2018893404. Epub 2019 May 31.